Wednesday, October 28, 2020

Tag: CoronaVirus Essential Business

Galectin Therapeutics (GALT) is Due for a COVID-19 Makeover

Galectin Therapeutics Inc. (NASDAQ: GALT) shot up close to 32.4% on Monday on record breaking volume of 4.9 million shares in anticipation of a long awaited investor conference call at 4PM ET on September 29th. In after hours trading the stock continues to climb to $4.20. GALT has one of the worst track records when it comes to shareholder communications with only 9 press releases this year, so it's easy to see why shareholders might be excited and speculating on news during the conference. GALT’s long term holders have pointed to outgoing CEO Harold Shlevin for the lack of communication while he focused on finishing the NASH phase 3 clinical trial design which took close to 2 years to complete.

The Covid-19 Vaccine is here, and the Winner Is

The goal in the US is to have a vaccine ready for at least some use by year end. Given the stringent approval process by the US FDA, it could be safe to say that another country may beat us to it. China and Russia have both made claims to this effect. But how safe will they be? Will there be any lasting side effects?

The best Education Technology “EdTech” Stocks to Own

Online education and tutoring in general is a vastly profitable market, especially in the wake of the COVID-19 pandemic. Moreover, if there is one area in particular where online education and tutoring possesses especially large business opportunities with even greater growth potential, it is China.

Food and Beverage Stocks in the Covid-19 Era

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Your Week In Brief; Bet on Political Volatility and Market Stability

Maher was right: Trump would rather set a fuse to our democracy than admit defeat. Even in the unlikely event of a blowout Biden victory, Trump will stay in office until a deep state statesman tosses him out. One thing the conspiracy-obsessed Trump supporters do have right is that thereis indeed a deep state despite Trump’s efforts to replace everyone in the government with sycophants. At least I hope so; we will need them.

Healthcare to reduce the cost of medical – It’s not just...

Marble Arch Research notes that PetVivo (OTCQB: PETV)achieved a major funding milestone last month, removing the main obstacle to its product commercialization goals. Commercial production of its disruptive osteoarthritis treatment device, Kush®, for canines and equines, a market we estimate is worth ~$3BN in the US alone, is due to commence in September 2020.

Covid-19 brings out a fitness craze and brings up Fitness stocks

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Top Stocks in the Education Space

In light of Early’s article, let us consider another education company: China Education Resources Inc. ("CER” or “the Company”). CER is perfectly poised to cater towards the intensified e-learning market demands which have arisen as a direct result of the COVID-19 pandemic. Based in Vancouver, Canada, CER is a publicly-listed ed-tech company (TSX-V:CHN and OTCQB:CHNUF) with leading technology in intelligent system and contents.

Why VBI Vaccines (NASDAQ: VBIV) Could Be a Contrarian Investor’s Dream

While the list of those garnering the most attention read like the usual suspects, there’s probably one biotech firm you haven’t heard of, VBI Vaccines (NASDAQ:VBIV). While VBIV stock soared to multi-year highs around mid-July, shares have found themselves plummeting back to earth. As several now well-known vaccine companies have entered into late-stage clinical trials for their Covid-19 candidates, the other, smaller names have lost their luster.

Stocks to be in before 2021

Glucose Health, Inc. is an under-the-radar company whose GLUCODOWN® products are found in major national pharmacy chains including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and even online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $20 million valuation.